Patient cost: $50 monthly copayment Benefit structure: The Medicare GLP-1 Bridge operates outside the standard Part D coverage and payment process
"Based on currently available information (primarily from clinical trials), the types of side effects associated with ecnoglutide are expected to be similar to those of existing GLP-1 receptor agonists (such as semaglutide or dulaglutide), primarily including gastrointestinal disorders (diarrhea, nausea, vomiting) and decreased appetite
Semaglutide helps regulate blood sugar and reduces your appetite, but certain supplements can enhance your metabolism, support digestion, and boost your energy levels
Avoid high-fat foods, high-fiber foods, caffeine, artificial sweeteners, and alcohol until symptoms improve
Many people find that room-temperature injections are more comfortable